Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up

Volume: 164, Issue: 2, Pages: 116 - 123
Published: Feb 1, 2010
Abstract
Background null Metformin has been proffered as a therapy for adolescent obesity, although long-term controlled studies have not been reported. null Objective null To test the hypothesis that 48 weeks of daily metformin hydrochloride extended release (XR) therapy will reduce body mass index (BMI) in obese adolescents, as compared with placebo. null Design null Multicenter, randomized, double-blind, placebo-controlled clinical trial. null Setting...
Paper Details
Title
Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up
Published Date
Feb 1, 2010
Volume
164
Issue
2
Pages
116 - 123
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.